Moderna Announces New Development Programs Ahead of 3rd Annual Vaccines Day - Digital Journal
3/22/2022 12:00:00 AM3 years 1 month ago
by ACCESSWIRE
by ACCESSWIRE
mRNA-1230 is a combination respiratory vaccine candidate against SARS-CoV-2 virus, influenza virus and respiratory syncytial virus (RSV)mRNA-1287 is a
mRNA-1230 is a combination respiratory vaccine candidate against SARS-CoV-2 virus, influenza virus and respiratory syncytial virus (RSV) mRNA-1287 is a vaccine candidate against the four endemic hum… [+5648 chars]
full article...